MONTELUKAST MYLAN

5MG TBL MND 7

SÚKL code 0165140
Name of the product MONTELUKAST MYLAN 5 MG
_MA_MEDICATION_DETAIL_INFO_MED_NAME i MONTELUKAST MYLAN
Supplement 5MG TBL MND 7
Strenght 5MG
Pharmaceutical form Chewable tablet
Package 7
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance MONTELUKAST SODIUM (MONTELUKASTUM NATRICUM)
ATC group R03DC03
ATC group name MONTELUKAST

Marketing authorisation information

Registration Number 14/ 235/11-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 01. 2019
MA Holder Generics [UK] Limited, Potters Bar
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list